Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000688866 | SCV000816493 | uncertain significance | Fanconi anemia | 2024-01-28 | criteria provided, single submitter | clinical testing | This sequence change replaces tyrosine, which is neutral and polar, with histidine, which is basic and polar, at codon 413 of the FANCM protein (p.Tyr413His). This variant is present in population databases (rs138225703, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with breast cancer (PMID: 30426508). ClinVar contains an entry for this variant (Variation ID: 568489). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000763928 | SCV000894872 | uncertain significance | Spermatogenic failure 28; Premature ovarian failure 15 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001535656 | SCV001805174 | uncertain significance | not provided | 2024-10-14 | criteria provided, single submitter | clinical testing | Observed in individuals with breast, ovarian, or colorectal cancer, and also in unaffected controls (PMID: 27713038, 28881617, 30426508, 34326862); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30426508, 27713038, 28881617, 34326862) |
Institute for Clinical Genetics, |
RCV001535656 | SCV002011503 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001771942 | SCV002030206 | uncertain significance | Spermatogenic failure 28 | 2021-02-09 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Sema4, |
RCV002256466 | SCV002527310 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-10-08 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001535656 | SCV004218714 | likely benign | not provided | 2022-07-13 | criteria provided, single submitter | clinical testing | |
Genome |
RCV001535656 | SCV001749710 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 04-02-2019 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. | |
Prevention |
RCV004535713 | SCV004119874 | uncertain significance | FANCM-related disorder | 2024-05-09 | no assertion criteria provided | clinical testing | The FANCM c.1237T>C variant is predicted to result in the amino acid substitution p.Tyr413His. This variant has been reported in an individuals with breast cancer and/or ovarian cancer, and it has also been reported in controls (Supplemental Table 2, Schubert et al. 2019. PubMed ID: 30426508; Table S4 in Bhai et al. 2021. PubMed ID: 34326862; Supplemental Material in Broderick et al. 2016. PubMed ID: 27713038). This variant is reported in 0.14% of alleles in individuals of European (Non-Finnish) descent in gnomAD and has been interpreted as variant of uncertain significance in the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/568489/). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |